Safety and Efficacy of Anorectal Application of Dx-gel for Treatment of Anal Incontinence

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

35

Participants

Timeline

Start Date

February 29, 2004

Primary Completion Date

January 31, 2009

Study Completion Date

May 31, 2009

Conditions
Fecal Incontinence
Interventions
PROCEDURE

Anal injection of Nasha Dx

Submucous injection of Nasha Dx 5-10 mm above dentate line

Trial Locations (1)

Unknown

Department of Surgery, University Hospital, 751 82 Uppsala

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Galderma R&D

INDUSTRY

lead

Uppsala University Hospital

OTHER

NCT01380132 - Safety and Efficacy of Anorectal Application of Dx-gel for Treatment of Anal Incontinence | Biotech Hunter | Biotech Hunter